Diabetes is a mutifactorial metabolic disorder that leads to a number of complications. Diabetes is estimated to affect 36 million people in the U.S.A., and the prevalence of diagnosed and undiagnosed diabetes is at 9.3% and continues to rise. Evidence from experimental animal models as well as humans has indicated that systemic inflammation plays a role in the pathophysiological processes of diabetes and is facilitated by innate immune responses. TLRs (Toll-like receptors) are key innate immune receptors that recognize conserved PAMPs (pathogen-associated molecular patterns), induce inflammatory responses essential for host defences and initiate an adaptive immune response. Although TLR expression is increased in a plethora of inflammatory disorders, the effects of metabolic aberrations on TLRs and their role in diabetes and its complications is still emerging. In the present paper, we provide a systematic review on how TLRs play a detrimental role in the pathogenic processes [increased blood sugar, NEFAs (non-esterified ‘free’ fatty acids), cytokines and ROS (reactive oxygen species)] that manifest diabetes. Furthermore, we will highlight some of the therapeutic strategies targeted at decreasing TLRs to abrogate inflammation in diabetes that may eventually result in decreased complications.
Skip Nav Destination
Article navigation
Review Article|
October 28 2011
Toll-like receptors and diabetes: a therapeutic perspective Available to Purchase
Mohan R. Dasu;
1Department of Dermatology, University of California Davis, Sacramento, CA 95816, U.S.A.
Correspondence: Dr Mohan R. Dasu (email [email protected]).
Search for other works by this author on:
Sandra Ramirez;
Sandra Ramirez
1Department of Dermatology, University of California Davis, Sacramento, CA 95816, U.S.A.
Search for other works by this author on:
Roslyn R. Isseroff
Roslyn R. Isseroff
1Department of Dermatology, University of California Davis, Sacramento, CA 95816, U.S.A.
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
July 12 2011
Revision Received:
September 01 2011
Accepted:
September 08 2011
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© The Authors Journal compilation © 2012 Biochemical Society
2012
Clin Sci (Lond) (2012) 122 (5): 203–214.
Article history
Received:
July 12 2011
Revision Received:
September 01 2011
Accepted:
September 08 2011
Citation
Mohan R. Dasu, Sandra Ramirez, Roslyn R. Isseroff; Toll-like receptors and diabetes: a therapeutic perspective. Clin Sci (Lond) 1 March 2012; 122 (5): 203–214. doi: https://doi.org/10.1042/CS20110357
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |